YOR389W Antibody is a specialized immunological reagent designed to detect the YOR389W protein in Saccharomyces cerevisiae (Baker’s yeast). This antibody is critical for studying the gene product of the YOR389W locus, which shares homology with YPL277C and is implicated in cellular processes such as ion tolerance and transcriptional regulation .
Gene Name: YOR389W
UniProt ID: Q08912
Species: Saccharomyces cerevisiae (strain ATCC 204508 / S288c)
Antibody Target: A protein of unknown function but linked to transcriptional repression via interactions with Rim101p, a pH-response regulator .
Contains a conserved TGCCAAG motif upstream of its coding sequence, indicative of potential regulatory elements .
Upregulated in rim101Δ mutants (22.6-fold compared to wild type), suggesting Rim101p acts as its repressor .
Studies reveal that YOR389W is part of a network regulated by Rim101p, which governs ion homeostasis and cell wall integrity. The table below highlights differential expression in yeast mutants :
| Gene | rim101Δ/wt Ratio | PacC Sites | Rim101p Binding |
|---|---|---|---|
| YOR389W | 22.6 | 1 | Yes |
The high rim101Δ/wt ratio indicates YOR389W is significantly derepressed in the absence of Rim101p.
YOR389W Antibody (Product Code: CSB-PA600151XA01SVG) has been validated for applications such as:
| Parameter | Detail |
|---|---|
| Host Species | Rabbit |
| Reactivity | Saccharomyces cerevisiae |
| Size Availability | 2 mL or 0.1 mL |
| Conjugate | Unconjugated |
YOR389W shares sequence similarity with YPL277C, another yeast protein of unknown function. Both genes are co-regulated by Rim101p and exhibit overlapping expression patterns under stress conditions .
Sample Preparation: Avoid denaturation methods that alter epitope accessibility (e.g., extreme pH or detergents) .
Controls: Use knockout yeast strains to validate specificity, as demonstrated in YCharOS protocols .
Cross-Reactivity: No reported cross-reactivity with other yeast proteins, but preadsorbed secondary antibodies are recommended to reduce background .
KEGG: sce:YOR389W
STRING: 4932.YOR389W
YOR389W is an open reading frame in the yeast genome that encodes a protein whose function remains to be fully characterized. Antibodies against YOR389W are valuable tools for detecting and studying this protein in various experimental contexts. These antibodies enable researchers to investigate protein expression, localization, interaction partners, and post-translational modifications. YOR389W has been studied in relation to other yeast proteins such as those in the Rim101p pH response pathway, making antibodies against it important for understanding fundamental cellular processes in yeast .
YOR389W antibodies are primarily used in several molecular biology techniques including:
Western blotting/immunoblotting to detect and quantify YOR389W protein expression in cell lysates
Immunoprecipitation to isolate YOR389W and its interaction partners
Immunofluorescence microscopy to study subcellular localization
Chromatin immunoprecipitation (ChIP) if YOR389W has DNA-binding properties
For Western blotting applications, YOR389W antibodies are typically used with specific protocols involving SDS-PAGE separation of proteins, transfer to nitrocellulose membranes, and detection using horseradish peroxidase (HRP)-conjugated secondary antibodies and ECL detection reagents .
Proper validation of YOR389W antibodies is critical for ensuring research reproducibility. Researchers should:
Test antibody specificity using knockout (KO) controls - ideally using a YOR389W deletion strain
Perform titration experiments to determine optimal concentration
Validate across different applications (Western blot, immunoprecipitation, etc.)
Compare results from different antibody clones/sources when possible
Include appropriate positive and negative controls in all experiments
Recent studies have shown that approximately 50% of commercial antibodies fail to meet basic characterization standards, highlighting the importance of validation before experimental use . For Western blot applications specifically, knockout cell lines have been demonstrated to be superior to other types of controls .
Several epitope tags have been successfully used with yeast proteins, including YOR389W:
V5 epitope tag - Detected using anti-V5-horseradish peroxidase antibody (typically at 1:5,000 dilution)
Hemagglutinin (HA) epitope tag - Detected using anti-HA-peroxidase antibody (typically at 1:10,000 dilution)
These epitope tags can be genetically fused to YOR389W to enable detection using commercially available tag-specific antibodies, which often have better characterized specificity than antibodies raised against the native protein itself .
Cross-reactivity is a common challenge with antibodies in yeast research. To overcome this issue:
Use pre-adsorption techniques with lysates from YOR389W knockout strains to remove non-specific antibodies
Implement more stringent washing conditions in immunoblotting protocols
Consider using monoclonal antibodies which typically have higher specificity than polyclonal antibodies
Employ epitope-tagged versions of YOR389W and corresponding tag antibodies
Validate specificity through peptide competition assays
Recent research has shown that recombinant antibodies generally outperform both monoclonal and polyclonal antibodies across multiple assays . When available, these should be preferred for critical experiments requiring high specificity.
For successful immunoprecipitation of YOR389W:
Harvest yeast cells during exponential growth phase and prepare cell lysates under conditions that preserve protein-protein interactions
Use a lysis buffer containing appropriate detergents (typically 1% NP-40 or Triton X-100) and protease inhibitors
Pre-clear lysates with protein A/G beads to reduce non-specific binding
Incubate cleared lysates with YOR389W antibody overnight at 4°C
Capture antibody-protein complexes using protein A/G beads
Wash extensively with decreasing detergent concentrations
Elute proteins for downstream analysis (e.g., mass spectrometry)
For co-immunoprecipitation studies investigating YOR389W interactions with Rim pathway proteins, consider crosslinking approaches to stabilize transient interactions, as these may be particularly important for understanding YOR389W's functional role .
Some yeast proteins, such as Rim101p, undergo proteolytic processing as part of their activation mechanism. If YOR389W undergoes similar processing:
Use SDS-PAGE conditions that can resolve small differences in molecular weight (e.g., 9% acrylamide gels)
Compare migration patterns of epitope-tagged constructs of full-length and truncated versions of YOR389W
Use antibodies raised against different regions of YOR389W that may differentially recognize processed forms
Employ genetic controls with mutations in relevant processing enzymes
Consider using Phos-tag gels if phosphorylation-dependent mobility shifts are suspected
Studies on Rim101p have successfully distinguished between processed and unprocessed forms using immunoblotting techniques, and similar approaches may be applicable to YOR389W if it undergoes post-translational modifications .
To investigate interactions between YOR389W and Rim101p pathway components:
Perform reciprocal co-immunoprecipitation experiments using antibodies against YOR389W and Rim101p pathway proteins
Employ yeast two-hybrid assays to detect direct protein-protein interactions
Use BiFC (Bimolecular Fluorescence Complementation) to visualize interactions in vivo
Consider proximity-based labeling techniques such as BioID or APEX
Analyze genetic interactions through epistasis studies with double mutants
Assess functional consequences of disrupting interactions on pH response or other relevant phenotypes
The Rim101p pathway involves multiple proteins including Rim8, Rim9, Rim13, Rim20, and Rim21 . Understanding YOR389W's potential role in this pathway would require systematic studies of its interactions with each component.
Proper controls are critical for antibody-based experiments with YOR389W:
| Application | Essential Controls |
|---|---|
| Western Blot | YOR389W knockout strain lysate; loading control (e.g., Pgk1p); positive control (known YOR389W-expressing strain) |
| Immunoprecipitation | IgG-only control; irrelevant antibody control; input sample; YOR389W knockout strain |
| Immunofluorescence | Secondary antibody-only control; YOR389W knockout strain; known localization marker co-staining |
| ChIP | IgG control; input DNA; negative region control; YOR389W knockout strain |
Recent research has demonstrated that knockout controls are particularly valuable for validating antibody specificity in both Western blot and immunofluorescence applications . An estimated 12 publications per protein target include data from antibodies that fail to recognize their intended target, highlighting the essential nature of proper controls .
For optimal YOR389W detection by immunoblotting:
Sample preparation: Grow cells overnight in selective medium at 30°C and use to inoculate YPD at an OD600 of 0.25. After two doublings, pellet cells and resuspend at an OD600 of 50 in 3× Laemmli buffer
Protein extraction: Vortex samples with glass beads and boil for 5 minutes to ensure complete protein extraction
Gel electrophoresis: Use 9% SDS-PAGE gels for optimal resolution
Transfer: Transfer proteins to nitrocellulose membrane using standard protocols
Blocking: Block membrane with 5% non-fat milk or BSA in PBS-Tween
Primary antibody: Incubate with anti-YOR389W antibody at optimized dilution (or anti-tag antibody if using tagged protein)
Secondary antibody: For V5-tagged proteins, use anti-V5-HRP at 1:5,000 dilution; for HA-tagged proteins, use anti-HA-peroxidase at 1:10,000 dilution
Detection: Visualize using ECL detection reagents with appropriate exposure times
This protocol is based on successful detection of epitope-tagged yeast proteins in published research .
To maintain antibody performance over time:
Store antibodies according to manufacturer recommendations (typically -20°C or -80°C for long-term storage)
Avoid repeated freeze-thaw cycles by preparing small aliquots
Add preservatives like sodium azide (0.02%) to antibody solutions stored at 4°C
Monitor antibody performance over time with consistent positive controls
Record lot numbers and batch information to track potential variability
Consider adding stabilizing proteins like BSA (0.1-1%) if diluting antibodies for storage
Test antibody activity periodically, especially before critical experiments
Proper storage and handling are essential since antibody performance can degrade over time, potentially leading to inconsistent results and reduced reproducibility in experiments .
YOR389W antibodies can be adapted for high-throughput applications through:
Microarray-based antibody assays for screening protein interactions
Automated Western blotting platforms for expression analysis across multiple conditions
Integration with robotic liquid handling systems for immunoprecipitation
Adaptation to ELISA formats for quantitative analysis
Multiplexed immunofluorescence approaches for co-localization studies
These approaches allow researchers to systematically study YOR389W function across various genetic backgrounds, environmental conditions, or in response to chemical perturbations.
Generating specific antibodies against YOR389W faces several challenges:
Sequence conservation with related proteins that may cause cross-reactivity
Potential post-translational modifications that may mask epitopes
Conformational epitopes that may not be preserved in denatured protein preparations
Limited immunogenicity of certain protein regions
Variability in antibody production between immunized animals or production batches
It is estimated that approximately 50-75% of proteins like YOR389W can be reliably detected by at least one high-performing commercial antibody . This suggests that while challenges exist, they can be overcome with proper antibody development and validation strategies.
Mass spectrometry can complement YOR389W antibody studies by:
Confirming antibody specificity by identifying proteins in immunoprecipitated samples
Characterizing post-translational modifications not detectable by antibodies alone
Identifying interaction partners in complex pull-down experiments
Providing absolute quantification of protein levels through techniques like MRM
Detecting YOR389W in samples where antibody-based methods may be challenging
An integrated approach combining antibody-based detection with mass spectrometry provides more comprehensive and reliable research outcomes, especially for proteins that may have multiple isoforms or modifications.
Emerging antibody technologies that could advance YOR389W research include:
Recombinant antibodies with improved specificity and batch-to-batch consistency
Nanobodies (single-domain antibodies) for accessing sterically hindered epitopes
Bi-specific antibodies for co-detection of YOR389W with interaction partners
Proximity-labeling antibodies for identifying spatial neighbors of YOR389W
Antibody fragments with enhanced penetration into subcellular compartments
Recent research has demonstrated that recombinant antibodies outperform both monoclonal and polyclonal antibodies across multiple assays, suggesting their adoption could significantly improve research quality .
To enhance reproducibility in YOR389W antibody research:
Use community-validated antibodies with published validation data
Participate in antibody characterization initiatives similar to YCharOS efforts
Report detailed antibody information in publications (catalog number, lot, dilution, validation methods)
Share detailed protocols including all buffer compositions and incubation conditions
Deposit raw data in repositories to enable reanalysis by other researchers
Consider using permanently available cell lines or genetic constructs as stable positive controls
The importance of proper antibody characterization cannot be overstated, as inadequately characterized antibodies are estimated to result in financial losses of $0.4–1.8 billion per year in the United States alone due to irreproducible research .
Computational methods can improve YOR389W antibody research through:
Epitope prediction algorithms to identify regions likely to generate specific antibodies
Homology analysis to identify potential cross-reactive proteins
Structural modeling to predict antibody-antigen interactions
In silico validation by comparing predicted epitopes against known protein domains
Database integration to aggregate validation data across multiple studies
These computational approaches, when combined with rigorous experimental validation, can significantly improve the quality and reproducibility of antibody-based research on YOR389W and other proteins.